TREA

90645222 - CUREBEST

Follow

Information

  • Trademark
  • 90645222
  • Serial Number
    90645222
  • Filing Date
    April 14, 2021
    3 years ago
  • Transaction Date
    February 09, 2024
    3 months ago
  • Status Date
    February 07, 2024
    3 months ago
  • Published for Opposition Date
    February 22, 2022
    2 years ago
  • Location Date
    April 19, 2022
    2 years ago
  • Status Code
    733
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    MANCA, ALBERTO I
  • Attorney Docket Number
    11333-1077
    Attorney Name
    Virginia Wolk Marino
    Law Office Assigned Location Code
    L80
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
CUREBEST
Case File Statements
  • PM0001: CURE BEST
  • GS0441: Providing medical and scientific testing and research information in the field of genetics; Providing information regarding medical diagnostic testing results and disease conditions for medical diagnosis purposes; Providing medical diagnostic testing, monitoring, analysis, evaluation and reporting services, and information related thereto in the field of genetics; Providing medical diagnostic testing, monitoring, analysis, evaluation and reporting services, and information related thereto in the field of cancer diagnosis; Gene, protein and cell analysis for medical diagnostic testing purposes; Medical analyses, in particular gene, protein and cell analyses for diagnosing cancer and forecasting the expected progress of a cancerous illness; Clinical laboratory testing service for medical diagnostic purposes specifically for forecasting and predicting a recurrence of cancer; Medical services, in particular, laboratory testing services comprising the analysis of biological samples for medical diagnostic purposes specifically for forecasting and predicting a recurrence of cancer
  • GS0421: Medical laboratory services, namely, clinical laboratory testing services and reporting of results for others for medical and scientific research purposes; Medical testing and research services in the field of genes, proteins and cells, and reporting of results for medical and scientific research purposes; Providing medical and scientific research information regarding diagnostic testing results and disease conditions; Providing laboratory research services in the field of gene expression; Gene expression analysis service for others in the nature of genetic testing for medical and scientific research purposes; Scientific research for medical purposes in the area of cancerous diseases; Medical research in the field of cancer diagnosis and cancer treatment; Providing medical and scientific research information in the field of forecasting and predicting a recurrence of cancer; Analytic and diagnostic testing services for medical and scientific research purposes, namely, the analysis of biological samples for forecasting and predicting a recurrence of cancer
Case File Event Statements
  • 2/9/2024 - 3 months ago
    39 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 2/7/2024 - 3 months ago
    38 - SOU EXTENSION 4 GRANTED Type: EX4G
  • 2/7/2024 - 3 months ago
    37 - SOU EXTENSION 4 FILED Type: EXT4
  • 2/7/2024 - 3 months ago
    36 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 8/12/2023 - 9 months ago
    35 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 8/10/2023 - 10 months ago
    34 - SOU EXTENSION 3 GRANTED Type: EX3G
  • 8/10/2023 - 10 months ago
    33 - SOU EXTENSION 3 FILED Type: EXT3
  • 8/10/2023 - 10 months ago
    32 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 3/1/2023 - a year ago
    31 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 2/27/2023 - a year ago
    30 - SOU EXTENSION 2 GRANTED Type: EX2G
  • 2/27/2023 - a year ago
    29 - SOU EXTENSION 2 FILED Type: EXT2
  • 2/27/2023 - a year ago
    28 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 8/5/2022 - a year ago
    27 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 8/3/2022 - a year ago
    26 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 8/3/2022 - a year ago
    25 - SOU EXTENSION 1 FILED Type: EXT1
  • 8/3/2022 - a year ago
    24 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 8/3/2022 - a year ago
    23 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 8/3/2022 - a year ago
    22 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Type: ECDR
  • 8/3/2022 - a year ago
    21 - TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Type: EWAF
  • 8/3/2022 - a year ago
    20 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 8/3/2022 - a year ago
    19 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 4/19/2022 - 2 years ago
    18 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 2/22/2022 - 2 years ago
    17 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 2/22/2022 - 2 years ago
    16 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 2/2/2022 - 2 years ago
    15 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 1/18/2022 - 2 years ago
    14 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 12/23/2021 - 2 years ago
    13 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 12/22/2021 - 2 years ago
    12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 12/22/2021 - 2 years ago
    11 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 10/13/2021 - 2 years ago
    10 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 10/13/2021 - 2 years ago
    9 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 10/13/2021 - 2 years ago
    8 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 10/5/2021 - 2 years ago
    7 - ASSIGNED TO EXAMINER Type: DOCK
  • 7/22/2021 - 2 years ago
    6 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 7/12/2021 - 2 years ago
    5 - PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED Type: AMPX
  • 7/12/2021 - 2 years ago
    4 - ASSIGNED TO LIE Type: ALIE
  • 6/28/2021 - 2 years ago
    3 - ASSIGNED TO LIE Type: ALIE
  • 4/20/2021 - 3 years ago
    2 - TEAS VOLUNTARY AMENDMENT RECEIVED Type: PARI
  • 4/17/2021 - 3 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP